Apollo Medical Hlds

Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It focuses on providing population health management and healthcare delivery platform. The company operates as an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.

Earnings data Q2 2020

Earnings data Q3 2020

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q3 2024

Apollo Medical Hlds reports robust 2022 performance and optimistic 2023 guidance

Apollo Medical Hlds delivered a strong financial performance in Q4 2022 and achieved record revenue for 2022, supported by membership growth and operational initiatives.
The company's focus on enhancing patient care through technology integration and strategic acquisitions positions it well for future growth.
While facing challenges in managing operational expenses, Apollo Medical Hlds has opportunities to drive innovation and expand its market presence in 2023.
Overall, Apollo Medical Hlds remains well-positioned with a solid financial foundation and a clear growth trajectory for the upcoming year.

Apollo Medical Hlds reports robust Q1 performance and growth opportunities

Apollo Medical Hlds showcased strong financial performance and operational goals for Q1 2023, despite challenges like unsuccessful contract renewals.
Membership growth, controlled medical loss ratios, and financial stability are key strengths for the company.
Opportunities in expanding membership, transitioning to risk contracts, and reaching Medicare member targets are on the horizon.

ApolloMed reports robust Q2 earnings, eyes growth through partnerships

Apollo Medical Hlds (AMEH) delivered a strong performance in Q2 2023, with notable revenue and EBITDA growth driven by membership expansion and strategic initiatives.
Despite facing challenges related to tax restatements and market uncertainties, the company remains well-positioned with a solid cash reserve and growth prospects.
With a focus on partnerships, acquisitions, and operational efficiency, ApolloMed is poised to capitalize on growth opportunities and enhance shareholder value.

Apollo Medical Holdings excels in Q3, eyes strategic growth

Apollo Medical Holdings demonstrated strong financial performance and strategic growth initiatives in Q3 2023, positioning them for continued success.
While facing challenges such as Medicaid redetermination and market dynamics, the company's focus on partnerships and financial management remains strong.
Opportunities for growth lie in expanding service offerings, geographic reach, and enhancing patient care through innovative partnerships.
Overall, ApolloMed's financial outlook, acquisitions, and partnerships indicate a positive trajectory for future growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam on November 1, 1985 and is headquartered in Alhambra, CA.

Investors need to pay close attention to Apollo Medical (AMEH) stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in Apollo Medical (AMEH) Stock?

HealthEquity

Medpace Holdings

The Zacks Medical - Services industry is growing on digital healthcare adoption. MEDP, HQY and AMEH are set to gain the most.

3 Medical Services Stocks to Buy Amid Improving Industry Trends

The average of price targets set by Wall Street analysts indicates a potential upside of 59.8% in Apollo Medical Holdings, Inc. (AMEH). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Believe Apollo Medical Holdings, Inc. (AMEH) Could Rally 59.78%: Here's is How to Trade

Apollo Medical Holdings, Inc. (AMEH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Apollo Medical Holdings, Inc. (AMEH) Upgraded to Strong Buy: Here's Why

Aspira Women’s Health 

McDonald's

Paycor HCM

Sandstorm Gold

AMEH, PYCR, AWH, SAND and MCD have been added to the Zacks Rank #1 (Strong Buy) List on May 11, 2023.

New Strong Buy Stocks for May 11th

Apollo Medical Holdings Inc. (NASDAQ:AMEH ) Q1 2023 Earnings Conference Call May 8, 2023 5:30 PM ET Company Participants Carolyne Sohn - VP of IR Brandon Sim - Co-CEO Chan Basho - Chief Financial Officer Conference Call Participants Ryan Daniels - William Blair Brooks O'Neil - Lake Street Capital Markets Adam Ron - Bank of America Operator Greetings. Welcome to Apollo Medical Holdings First Quarter 2023 Financial Results.

Apollo Medical Holdings Inc. (AMEH) Q1 2023 Earnings Call Transcript

Apollo Medical Holdings, Inc. (AMEH) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.31 per share a year ago.

Apollo Medical Holdings, Inc. (AMEH) Q1 Earnings and Revenues Surpass Estimates

Company to Host Conference Call on Monday, May 8, 2023, at 2:30 p.m. PT/5:30 p.m.

Apollo Medical Holdings, Inc. Reports First Quarter 2023 Results

Elevance Health Inc

Investors interested in Medical Services stocks are likely familiar with Elevance Health (ELV) and Apollo Medical Holdings, Inc. (AMEH). But which of these two companies is the best option for those looking for undervalued stocks?

ELV vs. AMEH: Which Stock Is the Better Value Option?

Apollo Medical Holdings, Inc. (AMEH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Apollo Medical Holdings, Inc. (AMEH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

ALHAMBRA, Calif. , April 26, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the first quarter ended March 31, 2023, after the close of the stock market on Monday, May 8, 2023.

Apollo Medical Holdings, Inc. Schedules 2023 First Quarter Financial Results Release and Conference Call

Apollo Medical Holdings Inc. (NASDAQ:AMEH ) Q4 2022 Results Conference Call February 24, 2023 8:30 AM ET Company Participants Carolyne Sohn - VP of IR Brandon Sim - Co-CEO Chan Basho - Chief Strategy Officer & Interim CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Jack Senft - William Blair Operator Greetings. Welcome to Apollo Medical Holdings Fourth Quarter and Year-end 2022 Financial Results.

Apollo Medical Holdings Inc. (AMEH) Q4 2022 Earnings Call Transcript

Apollo Medical Holdings, Inc. (AMEH) delivered earnings and revenue surprises of -77.78% and 11.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Apollo Medical Holdings, Inc. (AMEH) Lags Q4 Earnings Estimates

Company to Host Conference Call on Friday, Feb. 24, 2023, at 5:30 a.m. PT/8:30 a.m.

Apollo Medical Holdings, Inc. Reports Fourth Quarter and Year-End 2022 Results

ALHAMBRA, Calif. , Feb. 9, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the fourth quarter and year ended December 31, 2022, after the close of the stock market on Thursday, February 23, 2023.

Apollo Medical Holdings, Inc. Schedules 2022 Fourth Quarter and Year-end Financial Results Release and Conference Call

ALHAMBRA, Calif. , Jan. 22, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today released a statement regarding the mass shooting incident that took place in Monterey Park, Calif.

Apollo Medical Holdings, Inc. Releases Statement on the Mass Shooting in Monterey Park, Calif.

Agilysys

Kyndryl Holdings

Dorian LPG

Increased analyst coverage over the past few weeks may lead to solid price appreciation for stocks like Dorian (LPG), Agilysys (AGYS), Kyndryl (KD) and Apollo Medical (AMEH).

Analysts Initiate Coverage: 4 Stocks to Buy for Higher Return

ALHAMBRA, Calif. , Jan. 5, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that its wholly-owned subsidiary, APA ACO, Inc. ("APA ACO") generated $56.2 million in gross savings for the 2021 performance year, resulting in $48.8 million in shared savings from the Centers for Medicare & Medicaid Services ("CMS").

Apollo Medical Holdings, Inc. Announces APA ACO Achieved $48.8 Million in Shared Savings from Centers for Medicare and Medicaid Services for 2021 Performance Year

ALHAMBRA, Calif. , Dec. 20, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that leadership is presenting at the 41st Annual J.P.

Apollo Medical Holdings, Inc. to Participate in 41st Annual J.P. Morgan Healthcare Conference

ALHAMBRA, Calif. , Dec. 15, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that the Company's Board of Directors authorized a new share repurchase program, effective immediately, authorizing the purchase of up to $50 million of its shares of common stock.

Apollo Medical Holdings, Inc. Announces Share Repurchase Program

ALHAMBRA, Calif. , Nov. 17, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that ApolloMed received certification from the National Committee for Quality Assurance ("NCQA") for the Healthcare Effectiveness Data and Information Set ("HEDIS®"), following the development of its new HEDIS engine that identifies HEDIS gaps in care.

Apollo Medical Holdings, Inc. Receives NCQA's HEDIS Health Plan Measure Certification for Measurement Year 2022

Apollo Medical Holdings, Inc. (NASDAQ:AMEH ) Q3 2022 Earnings Conference Call November 4, 2022 8:30 AM ET Company Participants Carolyne Sohn - IR Brandon Sim - Co-CEO Chan Basho - Interim CFO Conference Call Participants Ryan Daniels - William Blair Sarah James - Barclays Operator Greetings and welcome to the Apollo Medical Holdings, Inc. Third Quarter 2022 Earnings Call. At this time all participants are in a listen-only mode.

Apollo Medical Holdings, Inc. (AMEH) Q3 2022 Earnings Call Transcript

Company to Host Conference Call on Friday, Nov. 4, 2022, at 5:30 a.m. PT/8:30 a.m.

Apollo Medical Holdings, Inc. Reports Third Quarter 2022 Results, Raises Revenue, Net Income and EBITDA Guidance for Full-Year 2022

ALHAMBRA, Calif. , Oct. 21, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the third quarter and nine months ended September 30, 2022, after the close of the stock market on Thursday, November 3, 2022.

Apollo Medical Holdings, Inc. Schedules 2022 Third Quarter Financial Results Release and Conference Call

ALHAMBRA, Calif. , Oct. 5, 2022 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it and its affiliated professional entity have entered into a definitive agreement to acquire 100% of the fully diluted capitalization and assets relating to nine primary care clinics in Las Vegas, Houston, and Fort Worth operating as Valley Oaks Medical Group ("VOMG").

News for Apollo Medical Hlds Stock (AMEH)